Clinical Trial

A Study to Evaluate the Safety and Pharmacokinetics of AG2304 Compared to Coadministration of AG23041 and AG23042

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated April 8, 2025 (before its estimated September 2025 completion). Its status may not reflect the trial's current state.
Summary
The objective of this study is to evaluate the pharmacokinetic characteristics of AG2304 in healthy subjects.
Trial Details
NCT Number NCT06916169
Lead Sponsor Ahn-Gook Pharmaceuticals Co.,Ltd
Conditions Pharmacokinetics
Enrollment 70 participants
Start Date 2025-08
Primary Completion 2025-09 (estimated)
Study Completion 2025-09 (estimated)
Updated on ClinicalTrials.gov 2025-04-08